Global Top 57 Best-Funded MedTech Startups: U.S. Leads with 77% of Funding Deals, Israel and UK Tie for Second

As the world’s largest medical device market, the United States boasts cutting-edge innovative technologies and robust R&D capabilities. Consequently, U.S.-based medical device startups have garnered favor from the majority of investors. In reality, however, medical device startups outside the United States are gradually emerging across the globe, attracting increasing attention from investors.

In 2017, the UK’s Atlas Genetics, Spain’s MedLumics, and Germany’s Breath Therapeutics all secured financing. Additionally, Israel, as one of the most active hubs in the medical device sector, saw its medtech giant Becton Dickinson acquire a majority stake in Caesarea Medical Electronics, a manufacturer of infusion and syringe pump systems, for $250 million in April 2017.

According to the latest report from CB Insights in the United States, the number of financing and investment transactions for global private medical device companies increased significantly in 2016, with a total of 479 deals completed and nearly $4.8 billion raised.In global medical device investment and financing transactions, the United States accounts for 77% of the transaction share, with Israel and the United Kingdom following closely behind.

On a quarterly basis, equity financing provided to private U.S. medical device companies increased from $675 million in the fourth quarter of 2016 to $163 million in the first quarter of 2017. Meanwhile, funding for medical device companies outside the United States decreased from $892 million in the fourth quarter of 2016 to $323 million in the first quarter of 2017, representing a 64% decline.

In the first quarter of 2017, among some larger-scale investment deals in the United States, Verily Life Sciences secured $800 million in funding from Temasek Holdings; Neuropace received a $50 million investment from Johnson & Johnson Innovation, Kleiner Perkins Caufield & Byers, and KCK Group; and the Israeli company CNoga Medical obtained $50 million in financing from BOE Technology Group.

Verily Life Sciences, a subsidiary of Alphabet, is dedicated to the development of devices such as compact glucose monitors, smart contact lenses, retinal imaging solutions, and surgical robots. Neuropace has developed an implantable neurostimulator that monitors brainwaves to prevent epileptic seizures. Meanwhile, CNoga Medical has developed non-invasive devices for measuring biological parameters, including blood glucose, blood pressure, and blood oxygen saturation.

Since the second quarter of 2015, equity transaction volumes for U.S. medical device companies have been on a downward trend, reaching a four-year low in the fourth quarter of 2016. However, in the first quarter of 2017, equity transactions for U.S. medical device companies rebounded to 132 deals, marking the first time since the third quarter of 2014 that transaction volume exceeded 130.

In the first quarter of 2017, equity transactions involving medical device companies outside the United States fell to 48 deals, after exceeding 50 deals for two consecutive quarters. However, the total volume of international investment and financing transactions in the medical device sector has been on a slow upward trend since reaching its lowest point in the third quarter of 2014.

Recent investment and financing transactions in the international medical device sector include: Finnish company Kide Systems secured $1.09 million in seed funding, primarily for the development of internet-connected optical imaging products; Israeli company EyeYon raised $6.5 million in Series A funding to develop an ophthalmic device for treating corneal edema; and Spanish company MedLumics obtained $37 million in Series B funding to advance its optical diagnostic technologies.

Since 2013, U.S. medical device startups have accounted for 77% of global financing and investment transactions, with Israel and the United Kingdom tied for second place at 4% each, followed by Canada and Germany tied for third place at 2% each.

The largest international investment deals since 2013 involved Japan’s Panasonic Healthcare, the UK’s Oxford Nanopore Technologies, and Israel’s Caesarea Medical Electronics. The “Others” category, accounting for 11% of the transaction share in the chart above, includes Biocartis (Switzerland) with an $85 million Series F financing round, Novadip Biosciences (Belgium) with a $31.3 million Series A financing round, and Trivitron Healthcare (India) with a $24.5 million equity financing round.

Based on its proprietary data, CB Insights tracks the financing activities of private medical device startups in the United States and globally, and has compiled a global map of medical device startups, highlighting thoseAt least 10 countries have three private medical device companies that rank among the top in national financing amounts.A total of 19 countries are featured on the map, covering 57 private medical device startups worldwide. Who are these companies? What are their core businesses? How is their financing status? VCBeat (WeChat ID: vcbeat) has compiled and organized information on these companies for readers’ reference.

1、Boreal Genomics

Total Financing Amount:$24.5 million

Boreal Genomics is a life sciences company that provides research tools and diagnostic tests for non-invasive tumor profiling and cancer monitoring. Boreal’s OnTarget platform performs highly sensitive genomic analysis of cell-free DNA in plasma to detect and quantify mutations in tumor-derived circulating nucleic acids.

2、Exact Imaging

Total Financing Amount:$21.2 million

Exact Imaging, formerly known as Imagistx, specializes in high-resolution micro-ultrasound systems capable of real-time imaging and guided biopsy for prostate cancer. Exact Imaging’s ExactVu is the world’s first 29-frequency micro-ultrasound platform, offering ultra-high resolution and ease of use, thereby extending existing urological workflows. Using this platform, urologists can visualize and localize suspicious areas within the prostate and perform targeted biopsies of these specific regions, providing a systematic biopsy approach.

3、Intellijoint Surgical

Total Financing Amount:USD 12.24 million

Intellijoint Surgical primarily develops commercialized surgical navigation solutions. Intellijoint’s flagship product, Intellijoint HIP, provides surgeons with real-time intraoperative measurements to ensure accurate positioning of orthopedic implants throughout total hip arthroplasty. Intellijoint is setting a new standard for miniature 3D surgical navigation.

1、Oxford Nanopore Technologies

Total Financing Amount:$496 million

Oxford Nanopore Technologies has developed MinION, a nanopore DNA sequencer. MinION is a portable, real-time, and low-cost device designed to provide accessible biological analysis for everyone, including applications in scientific research, education, and various real-world scenarios such as disease/pathogen surveillance, environmental monitoring, food chain monitoring, self-quantification, and microgravity biology. Since 2015, MinION has been deployed within a thriving community spanning more than 50 countries. Oxford Nanopore is dedicated to empowering every user with robust DNA/RNA analytical capabilities; therefore, the team is working to streamline sample preparation and data analysis processes.

2、Atlas Genetics

Total Financing Amount:$86.5 million

Atlas Genetics is headquartered and maintains its laboratories near Bath, UK, dedicated to developing ultra-rapid decentralized and point-of-care (POC) diagnostic tests for infectious diseases. The company’s Atlas io system utilizes patented novel electrochemical sensor technology, delivering best-in-class speed and accuracy.

3、Quanta Fluid Solutions

Total Financing Amount:$57.52 million

Quanta Fluid Solutions is developing advanced hemodialysis systems for use in clinics and at home. The company’s cartridge-based solution, SC+, is the only portable, compact hemodialysis system that delivers the clinical efficacy and high flow rates of traditional machines. Designed for ease of use and flexibility, SC+ facilitates self-care and enables dialysis treatment for patients throughout their care journey.

1、Retina Implant

Total Financing Amount:$46.27 million

Retina Implant primarily provides wireless retinal implant technology, developing subretinal implants for patients with visual impairments and blindness.

2、Breath Therapeutics

Total Financing Amount:$45.9 million

Breath Therapeutics is advancing an inhaled therapy for the treatment of bronchiolitis obliterans syndrome (BOS). BOS is a fatal orphan respiratory disease that primarily affects lung transplant recipients.

3、Invendo Medical

Total Funding Amount:$36.6 million

Invendo Medical is dedicated to developing disposable endoscopy products in the field of gastroenterology by leveraging computer-assisted and robotic technologies. Over the past few years, the company has integrated its suite of proprietary technologies into its disposable endoscopes. The product has gained market access in both the United States and the European Union.

1、General Medical Merate

Total Financing Amount:$16.15 million

General Medical Merate (GMM) primarily manufactures and provides X-ray diagnostic solutions, including radiography systems, remote control systems, and designated devices.

2、Movendo Technology

Total Financing Amount:$11.15 million

Movendo Technology is a subsidiary of the Italian Institute of Technology, primarily developing robotic platforms for lower-limb rehabilitation.

3、Silk Biomaterials

Total Financing Amount:$84.5 million

Silk Biomaterials is a medical technology startup whose primary initial objective is to develop technologies for manufacturing implantable medical devices. These devices are primarily composed of silk fibers and are designed for in vivo regeneration of human tissues.

1、4Tech

Total Financing Amount:$36 million

4Tech is dedicated to developing percutaneous solutions for the treatment of tricuspid valve disease. Its 4Tech TriCinch System for transcatheter tricuspid valve repair enables a simple and reproducible percutaneous procedure, allowing patients to regain their quality of life while also generating significant cost savings for healthcare systems.

2、VistaMed

Total Financing Amount:$20.72 million

VistaMed is a Spiral Healthcare joint venture that provides catheters to the global medical device industry. Established in 1999, the company operates two medical manufacturing facilities in Ireland: Carrick-on-Shannon & Rooskey and Co Leitrim. VistaMed’s product portfolio includes PTFE-lined guiding catheters, steerable catheters, balloon catheters, endoscopic catheters, ablation catheters, urology catheters, micro-infusion pain management catheters, and other ancillary devices such as introducers and dilators. Utilizing medical-grade thermoplastics such as PEEK, polyurethane, polycarbonate, and nylon, VistaMed manufactures single-lumen, multi-lumen, triple-layer, co-extruded, micro-extruded, bumped, braided, and wire-reinforced tubing for complex medical catheter systems. The company is ISO 13485 certified and FDA registered.

3、Vivasure Medical

Total Financing Amount:$18.23 million

Vivasure Medical has developed a patented bioresorbable implant platform technology for vascular closure devices. The first product in its PerQseal platform features a bioresorbable implant and a percutaneous delivery system, designed to close large arteriotomies.

1、Sequana Medical

Total Financing Amount:$60.5 million

Sequana Medical, formerly known as Novashunt, is dedicated to improving patients’ lives through innovative technologies that address fluid overload in individuals suffering from liver disease, cancer, and congestive heart failure. The company’s core technology is a fully implantable pump system designed to redirect excess fluid to the bladder for natural elimination through normal urination. Its first product, the alfapump system, is a solution for managing ascites, which is the accumulation of fluid in the abdominal cavity in patients with advanced liver disease, certain cancers, or congestive heart failure. As the first and only automated, continuous system for ascites removal, the alfapump system entered the European market in 2011. Additionally, other applications of this pump technology are currently under development.

2、Sensimed

Total Financing Amount:$42.02 million

Sensimed is a Swiss medical device company that has developed a solution for continuous 24-hour monitoring of intraocular pressure fluctuations in patients. The solution consists of a soft, non-invasive contact lens embedded with a telemetry sensor. The external system includes a portable recording device with an adhesive antenna.

3、G-Therapeutics

Total Financing Amount:$40.8 million

G-Therapeutics has developed an implantable neurostimulator for patients with incomplete spinal cord injury. The company’s therapeutic approach creates an environment conducive to the brain’s self-repair. G-Therapeutics is developing an implantable stimulation system and a robot-assisted training program to help patients with spinal cord injury recover their health.

1、BoneSupport

Total Financing Amount:$79.9 million

BoneSupport specializes in treating orthopedic trauma with injectable bone graft substitutes, with its products primarily applied in the management of bone infections, instrument augmentation, and spinal procedures. CERAMENT is an injectable synthetic bone substitute that mimics the properties of cancellous bone, allowing for controlled resorption to support future bone ingrowth, and is suitable for injection under local anesthesia during minimally invasive surgeries. The unique biological characteristics of CERAMENT provide a consistent, pre-packaged, and ready-to-use formulation to facilitate optimal delivery. CERAMENT | G is the first CE-marked injectable gentamicin-eluting ceramic bone graft substitute. CERAMENT | G is set to be launched in CE-marked countries to promote bone healing in the treatment of osteomyelitis.

2、OssDign

Total Financing Amount:USD 12.83 million

OssDign, formerly known as Oss-Q, primarily develops bone substitute implants based on its bioceramic technology. Multicenter clinical studies utilizing the company’s first product, OssDsign Cranio PSI, will be conducted to evaluate clinical outcomes, quality of life, and health economics.

3、Promimic

Total Funding Amount:$12.8 million

Promimic is a biomaterials company that develops and markets unique implant surfaces to accelerate osseointegration. The company’s HAnano surface can be applied to various types of substrates, including metals, ceramics, and polymers. It can transform any implant, regardless of its size and structure, into a surface resembling natural human bone tissue.

1、Vivostat

Total Financing Amount:$13.3 million

Vivostat offers a simple, fully automated method for preparing fibrin sealant from the patient’s own blood.

2、Acarix

Total Financing Amount:$4.7 million

Acarix has developed the CADScor system for the early diagnosis of coronary artery disease (CAD). The system primarily diagnoses the condition by recording cardiac acoustic murmurs caused by coronary stenosis. The device is comparable in size to a mobile phone and connects to the patient’s chest via a specially developed patch.

3、FBC Device

Total Financing Amount:$3.73 million

FBC Device is a medical device company focused on developing spinal implants to improve the treatment of degenerative disc disease. The company has developed a novel spinal fusion implant with unique features that allow it to conform to the patient’s anatomy, enabling restoration of natural balance.

1. WuXi AppTec (WuXi Kangde)

Total Funding Amount:$72.72 million (excluding funds raised after the IPO)

WuXi AppTec, also known as WuXi Biologics, is a globally leading open-access capability and technology platform company for the research and development of pharmaceuticals, biotechnology, and medical devices, with business operations in both China and the United States. WuXi AppTec provides a comprehensive range of laboratory R&D and research-to-production services to global pharmaceutical companies, biotechnology firms, and medical device manufacturers, covering the entire process from drug discovery to market launch. The company aims to help global clients shorten the R&D cycle for drugs and medical devices and reduce R&D costs through cost-effective and efficient R&D services.

2. Xinrong Best Medical Instrument Co. (Xinrong Medical)

Total Financing Amount:$100 million

Xinrong Best Medical Instrument Co., Ltd. (Suzhou Xinrong Medical Device Co., Ltd.) is a specialized manufacturer of orthopedic medical devices. The company primarily produces hip joint prostheses, spinal internal fixation systems, locked intramedullary nails, threaded bone plates and screws, as well as related specialized surgical instruments. The company possesses first-class product manufacturing technologies and process equipment, and is one of the first batch of entities in China to pass the simulated pilot inspection for compliance with the Good Manufacturing Practice (GMP) for Medical Devices, which governs the quality management systems of medical device manufacturers.

3. Venus Medtech (Qiming Medical)

Total Financing Amount:$66.98 million

Venus Medtech is a medical device company dedicated to the minimally invasive treatment of heart valve diseases, holding a leading position in China and winning the National Grand Prize in the Biopharmaceutical Category of the 3rd National Innovation and Entrepreneurship Competition. Its transcatheter aortic valve product, Venus A-Valve, ranks first globally and is the only transcatheter aortic valve product that has completed the clinical trials required by the CFDA, possessing fully independent intellectual property rights.

1、Signostics

Total Funding Amount:$44 million

Signostics is a developer of handheld ultrasound devices and bladder scanners. The company’s patented product, the SignosRT Bladder Scanner, is a device that utilizes ultrasound technology to automatically detect the bladder and calculate its volume.

2、Bionic Vision Technology

Total Financing Amount:$18 million

Bionic Vision Technologies (BVT) is an Australian company primarily developing visual prostheses to restore vision in blind individuals. The device functions by delivering electrical stimulation to the remaining retinal cells in patients with retinal degeneration.

3、Atomo Diagnostics

Total Financing Amount:US$13.07 million

Atomo Diagnostics is a professional medical device design and original equipment manufacturing (OEM) company whose unique proprietary technologies enhance the usability, accuracy, and safety of its devices. The company is committed to delivering best-in-class performance by enabling rapid diagnostic testing through innovative, integrated test devices. It is currently commercializing a portfolio of user-friendly rapid diagnostic devices and services, providing clinical and economic value to healthcare consumers and providers worldwide.

1、InSightec

Total Financing Amount:$188 million

InSightec is a provider of Magnetic Resonance-guided Focused Ultrasound (MRgFUS). Founded in 1999, the company has developed a completely non-invasive therapeutic platform for the treatment of neurological, oncological, and gynecological conditions. MRgFUS has been adopted by more than 120 leading medical institutions worldwide, which have recognized the significant clinical and economic value of InSightec’s treatment platform.

2、EarlySense

Total Funding Amount:$88 million

EarlySense provides contactless, continuous monitoring solutions for the medical and consumer digital health markets. EarlySense’s patented sensors and advanced algorithms monitor and analyze cardiac, respiratory, sleep, and movement parameters. For hospitals and healthcare institutions worldwide, EarlySense helps clinicians detect patient deterioration early, thereby preventing adverse events such as emergency resuscitation, ICU transfers, patient falls, and pressure ulcers. Furthermore, through EarlySense’s smart home-compatible solutions, which bring hospital-validated technology into the home, users can share their health and sleep data with their physicians.

3、Bio Control Medical

Total Financing Amount:$70 million

Bio Control Medical provides implantable devices for the treatment of incontinence and congestive heart failure.

1、EndoMaster

Total Financing Amount:USD 15.02 million

EndoMaster is a medical device company based in Singapore that has developed a novel robot-assisted surgical system.

2、AWAK Technologies

Total Financing Amount:$11.2 million

AWAK Technologies is a medical technology company dedicated to improving patients’ lives and co-creating a better tomorrow. The company has developed a proprietary sorbent technology that revolutionizes dialysis by continuously recovering and regenerating dialysate, thereby reducing the volume of dialysate required for treatment. This technology enables the development of lightweight, compact, automated, wearable, and portable medical devices.

3、Racer Technology

Total Financing Amount:$1.33 million

Racer Technology is a medical device manufacturer headquartered in Singapore, with its sales team primarily based in California, USA. The company mainly manufactures respiratory devices, cochlear hearing aids, and diagnostic and therapeutic equipment.

1、Prognosys Medical Systems

Total Financing Amount:$33.23 million

Prognosys Medical Systems, established in 2003 and headquartered in Bangalore, India, primarily develops and manufactures radiology, imaging, and telehealth products.

2、Perfint Healthcare

Total Financing Amount:$29.23 million

Perfint Healthcare is a world leader in image-guided interventional therapy solutions, with its core business focused on oncology and pain management. Perfint’s products have been installed in some of the world’s top hospitals and have obtained CE certification. Radiologists worldwide utilize Perfint’s robotic solutions to perform image-guided interventional procedures, such as biopsies, drug delivery, ablation, drainage, fine-needle aspiration, and various pain management interventions for both cancerous and non-cancerous pain.

3、SMT

Total Financing Amount:$25 million

Sahajanand Medical Technologies (SMT) is a leading developer and manufacturer of minimally invasive coronary stent systems, with a strong presence in over 40 countries worldwide. SMT was the first company to receive CE certification for a biodegradable polymer drug-eluting stent. The company’s main products include drug-eluting stents, bare-metal stents, balloon catheters, and inflation devices.

1、Valkee

Total Financing Amount:$10.33 million

Valkee is a health technology company dedicated to developing light therapy technologies that use bright light to uplift people’s mood, thereby reducing the need for antidepressant medications. Developed in collaboration with the University of Oulu in Finland, Valkee launched the world’s first portable bright light therapy device, the HumanCharger.

2、Synoste

Total Financing Amount:$6.25 million

Synoste is a Finnish company founded by three young engineering students, aiming to provide solutions for millions of people unfortunately affected by skeletal deformities. They seek to correct various types of bone deformities through technology, such as scoliosis and limb length discrepancies in the legs or arms.

3、Arctic Diagnostics

Total Financing Amount:$2.7 million

Arctic Diagnostics is a manufacturer of multi-analyte respiratory infection diagnostic systems based in Finland.

1、STAT-Diagnostics

Total Financing Amount:$53.44 million

STAT-Diagnostics is a Spanish medical diagnostics company dedicated to developing near-patient testing products for healthcare professionals, with its products primarily used in intensive care.

2、MedLumics

Total Financing Amount:$41.7 million

Medlumics is a Spanish medical device startup founded in 2009, dedicated to improving quality of life through biophotonics. Biophotonics integrates knowledge from biology, medicine, physics, and photonics, with the ultimate goal of developing diagnostic and therapeutic technologies that leverage the properties of optical radiation.

3、Transplant Biomedicals

Total Financing Amount:$4.22 million

Transplant Biomedicals is a company based in Barcelona, Spain, dedicated to developing novel medical strategies to improve the preservation of tracheas, tissues, and cells, thereby enhancing patients’ overall health. The company is developing new organ delivery devices for hospital use, which aim to improve therapeutic outcomes by increasing graft survival rates and reducing the risk of delayed graft function.

1、Novadip Biosciences

Total Financing Amount:$31.3 million

Novadip Biosciences is an advanced biopharmaceutical company focused on next-generation therapies using adipose-derived stem cells for hard and soft tissue reconstruction.

2、Nyxoah

Total Financing Amount:$30.94 million

Nyxoah is a pioneering medical device company founded in 2009, dedicated to developing novel diagnostic and therapeutic solutions for obstructive sleep apnea (OSA). Currently, Nyxoah is conducting clinical trials on a small, battery-free implantable neurostimulator. This device electrically stimulates the hypoglossal nerve to control tongue movement, thereby preventing airway obstruction.

3、iSTAR Medical

Total Financing Amount:$16.38 million

iSTAR Medical is a Belgian medical technology company dedicated to developing novel ophthalmic implants for patients with glaucoma. Founded in 2010, the company is headquartered in Wavre, Belgium. In 2012, iSTAR obtained ISO 13485 and ISO 9001 quality management system certifications, as well as CE marking for its first device, the STARflo™ glaucoma implant.

1、NightBalance

Total Financing Amount:$13.95 million

NightBalance BV, a company founded by TU Delft alumni in 2009, primarily developed the Sleep Position Trainer (SPT). NightBalance collaborates with various departments at TU Delft and several hospitals in the Netherlands, including Sint Lucas Andreas Hospital in Amsterdam and Medisch Spectrum Twente in Enschede. Currently, 18 hospitals are conducting research on this sleep position training device.

2、Fortimedix Surgical

Total Financing Amount:$12.11 million

Fortimedix is a global leader in endovascular stents, with comprehensive in-house stent development and manufacturing capabilities. Fortimedix Surgical is dedicated to advancing minimally invasive surgery by creating novel devices that capture the advantages required for single-port procedures.

3、NovioSense

Total Financing Amount:$2.1 million

NovioSense focuses on non-invasive glucose monitoring, using sensors to detect glucose levels in tears and thereby estimate the user's blood glucose level.

1、EyeTechCare

Total Financing Amount:$51.76 million

EyeTechCare, founded in 2008 and headquartered in Lyon, France, specializes in the development and marketing of medical devices for the non-invasive treatment of ocular diseases. The company has developed EyeOP1, an ultrasound device that provides non-invasive therapy for refractory glaucoma. This cutting-edge technological device is the result of years of collaborative research with INSERM and offers a treatment method using High-Intensity Focused Ultrasound (HIFU).

2、Biom'Up

Total Financing Amount:$45.9 million

Biom'Up is an expert in the field of absorbable biomaterials, specializing in the production of unique medical devices based on collagen technology. These innovative and clinically proven products cover many different surgical specialties, such as orthopedics, spine, and cardiac surgery, and improve patient healing by allowing guided regeneration of soft tissues and bone.

3、Gecko Biomedical

Total Financing Amount:$38.06 million

Gecko Biomedical is a privately held medical device company based in Paris, France, dedicated to the rapid development and commercialization of biodegradable sealants and surgical wound-closure adhesives, particularly for use in minimally invasive procedures.

1、Verily Life Sciences

Total Financing Amount:$800 million

Verily Life Sciences, formerly Google’s life sciences division, is dedicated to converging technology and the life sciences to uncover truths about health and disease. Verily’s multidisciplinary team leverages advanced research tools, large-scale computational capabilities, and unique technical expertise. They collaborate with industry professionals to develop new technologies and explore emerging fields.

2、Proteus Digital Health

Total Financing Amount:$417 million

Proteus Digital Health, founded in 2001 and headquartered in Redwood City, California, USA, is primarily engaged in the development and commercialization of digital health products. Its digital health solutions collect and aggregate various behavioral, physiological, and therapeutic metrics—such as medication adherence, heart rate, sleep patterns, physical activity, and stress levels—into personal management tools on users’ mobile devices.

3、Adaptive Biotechnologies

Total Financing Amount:$416 million

Adaptive Biotechnologies is a pioneer and leader in combining high-throughput sequencing with expert bioinformatics to analyze T-cell and B-cell receptors. The company brings the accuracy and sensitivity of its immune profiling platform to laboratories worldwide, driving breakthrough research in cancer and other immune-mediated diseases. Additionally, Adaptive is committed to translating immune profiling discoveries into clinical diagnostics and therapeutic development to improve patient care.

References:

1、https://www.cbinsights.com/blog/medical-device-most-well-funded-startups-global-map/

2、https://www.crunchbase.com/#/home/index